SCHEMBL25190261

SCHEMBL25190261

Fc1ccc(-c2cccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c2)cc1-c1cc2c3ccccc3sc2c2c1[nH]c1ccccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K9 P80192 3/20 0.40
▸ MAP3K11 Q16584 3/20 0.40
▸ CDK4 P11802 2/20 0.40
▸ CCND1 P24385 2/20 0.40
▸ TNKS O95271 2/20 0.38
▸ TNKS2 Q9H2K2 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ NTRK1 P04629 1/20 0.35
▸ MAP3K10 Q02779 1/20 0.35
▸ ALOX5 P09917 1/20 0.33
▸ HTT P42858 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CYP1A2 P05177 2/20 0.32
▸ PPARG P37231 1/20 0.32
▸ NCOA2 Q15596 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30388329 1.00 MAP3K9 (0.40) MAP3K9MAP3K11CDK4CCND1TNKS
SCHEMBL30388681 0.80 CDK4 (0.46) MAP3K9MAP3K11CDK4CCND1TNKS
SCHEMBL25195003 0.80 CDK4 (0.46) MAP3K9MAP3K11CDK4CCND1TNKS
SCHEMBL25201881 0.80 MAP3K11 (0.34) MAP3K9MAP3K11CDK4CCND1MEN1
SCHEMBL30388390 0.80 MAP3K11 (0.34) MAP3K9MAP3K11CDK4CCND1MEN1
SCHEMBL26011191 0.74 ALOX5 (0.52) TNKSTNKS2MEN1MAPTRAB9A
SCHEMBL19039831 0.74 MAP3K9 (0.36) MAP3K9MAP3K11CDK4CCND1TNKS
SCHEMBL15638451 0.73 KMT2A (0.49) MAP3K9MAP3K11CDK4CCND1TNKS
SCHEMBL25645935 0.73 ALOX5 (0.42) TNKSTNKS2MEN1MAPTKMT2A
SCHEMBL26047803 0.73 ALOX5 (0.42) TNKSTNKS2MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159550-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-25 — — US disclosed
US-20230159550-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-25 — — US disclosed
US-20230159550-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159550-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, ODC1 MAP3K9 3120/4885MAP3K11 3309/4885CDK4 1358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback